CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Feb. 01, 2020	$ 76,955	$ 172,885	$ (95,930)
Balance, beginning of period (in shares) at Feb. 01, 2020		13,955,826
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchases	35	$ 35
Employee stock purchases (in shares)		34,999
Restricted stock issued		32,341
Net share settlement of stock options and restricted stock	(8)	$ (8)
Net share settlement of stock options and restricted stock (in shares)		(8,663)
Stock-based compensation expense	307	$ 307
Net income (loss)	(7,438)		(7,438)
Balance, end of period at May. 02, 2020	69,851	$ 173,219	(103,368)
Balance, end of period (in shares) at May. 02, 2020		14,014,503
Balance, beginning of period at Feb. 01, 2020	76,955	$ 172,885	(95,930)
Balance, beginning of period (in shares) at Feb. 01, 2020		13,955,826
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 0
Repurchase and retirement of common stock (in shares)	0
Net income (loss)	$ (16,801)
Balance, end of period at Aug. 01, 2020	$ 60,812	$ 173,543	(112,731)
Balance, end of period (in shares) at Aug. 01, 2020	14,240,081	14,240,081
Balance, beginning of period at May. 02, 2020	$ 69,851	$ 173,219	(103,368)
Balance, beginning of period (in shares) at May. 02, 2020		14,014,503
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued		230,688
Net share settlement of stock options and restricted stock	(5)	$ (5)
Net share settlement of stock options and restricted stock (in shares)		(5,110)
Stock-based compensation expense	$ 329	$ 329
Repurchase and retirement of common stock (in shares)	0
Net income (loss)	$ (9,363)		(9,363)
Balance, end of period at Aug. 01, 2020	$ 60,812	$ 173,543	(112,731)
Balance, end of period (in shares) at Aug. 01, 2020	14,240,081	14,240,081
Balance, beginning of period at Jan. 30, 2021	$ 94,922	$ 174,391	(79,469)
Balance, beginning of period (in shares) at Jan. 30, 2021	14,292,250	14,292,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 52	$ 52
Exercise of stock options (in shares)		10,669
Restricted stock issued		30,087
Net share settlement of stock options and restricted stock	(257)	$ (257)
Net share settlement of stock options and restricted stock (in shares)		(11,339)
Stock-based compensation expense	232	$ 232
Repurchase and retirement of common stock	(1,356)		(1,356)
Repurchase and retirement of common stock (in shares)		(47,350)
Net income (loss)	1,719		1,719
Balance, end of period at May. 01, 2021	95,312	$ 174,418	(79,106)
Balance, end of period (in shares) at May. 01, 2021		14,274,317
Balance, beginning of period at Jan. 30, 2021	$ 94,922	$ 174,391	(79,469)
Balance, beginning of period (in shares) at Jan. 30, 2021	14,292,250	14,292,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 146
Repurchase and retirement of common stock (in shares)	(608,898)
Net income (loss)	$ 2,345
Balance, end of period at Jul. 31, 2021	$ 84,602	$ 175,090	(90,488)
Balance, end of period (in shares) at Jul. 31, 2021	13,805,130	13,805,130
Balance, beginning of period at May. 01, 2021	$ 95,312	$ 174,418	(79,106)
Balance, beginning of period (in shares) at May. 01, 2021		14,274,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	94	$ 94
Exercise of stock options (in shares)		20,168
Restricted stock issued		79,775
Net share settlement of stock options and restricted stock	(73)	$ (73)
Net share settlement of stock options and restricted stock (in shares)		(7,582)
Stock-based compensation expense	651	$ 651
Repurchase and retirement of common stock	$ (12,008)		(12,008)
Repurchase and retirement of common stock (in shares)	(561,548)	(561,548)
Net income (loss)	$ 626		626
Balance, end of period at Jul. 31, 2021	$ 84,602	$ 175,090	$ (90,488)
Balance, end of period (in shares) at Jul. 31, 2021	13,805,130	13,805,130